Endothelial progenitor cells (EPCs) are important to tissue repair and regeneration especially after ischemic injury, and very heterogeneous in phenotypes and biological features.
Reactive oxygen species are involved in regulating
EPC number and function.
N-acetylcysteine (NAC) inhibits
ischemia-induced
reactive oxygen species formation and promotes ischemic limb recovery. This study was to evaluate the effect of NAC on
EPC subpopulations in bone marrow (BM) and blood in mice with limb
ischemia. Limb
ischemia was induced by femoral artery
ligation in male C57BL/6 mice with or without NAC treatment.
EPC subpopulations, intracellular
reactive oxygen species production, cell proliferation and apoptosis in BM and blood cells were analyzed at baseline, day 3 (acute
ischemia) and 21 (chronic) after
ligation. c-Kit+/CD31+, Sca-1+/Flk-1+, CD34+/CD133+, and CD34+/Flk-1+ were used to define
EPC subpopulations. Limb blood flow, function, muscle structure, and capillary density were evaluated with
laser Doppler perfusion imaging, treadmill test, and immunohistochemistry, respectively, at day 3, 7, 14 and 21 post
ischemia.
Reactive oxygen species production in circulating and BM mononuclear cells and EPCs populations were significantly increased in BM and blood in mice with acute and chronic
ischemia. NAC treatment effectively blocked
ischemia-induced
reactive oxygen species production in circulating and BM mononuclear cells, and selectively increased
EPC population in circulation, not BM, with preserved proliferation in mice with chronic
ischemia, and enhanced limb blood flow and function recovery, while preventing acute
ischemia-induced increase in BM and circulating EPCs. These data demonstrated that NAC selectively enhanced circulating
EPC population in mice with chronic limb
ischemia.